Ethris

Ethris Utilizes Its Proprietary Non-Immunogenic mRNA Technology Platform to Discover, Design, and Develop Innovative Therapies, Paving a New Path from Genes to Therapeutic Proteins. As an mRNA Pioneer with Over a Decade of Experience, We Are the Global Leader in Delivering Stable mRNA Directly to the Respiratory System Through Optimized Formulations and Nebulization Technologies. We Are Rapidly Advancing Our Pipeline of Immunomodulatory and mRNA-Based Protein Replacement Therapies, with the Ultimate Goal of Improving Patients' Lives.